ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MDXG MiMedx Group Inc

7.97
-0.12 (-1.48%)
20 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
MiMedx Group Inc NASDAQ:MDXG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.12 -1.48% 7.97 7.74 7.99 8.13 7.955 8.00 334,244 21:30:00

MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31

17/07/2024 1:00pm

GlobeNewswire Inc.


MiMedx (NASDAQ:MDXG)
Historical Stock Chart


From Mar 2024 to Mar 2025

Click Here for more MiMedx Charts.

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 31, 2024. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click hereU.S. Investors: 877-407-6184International Investors: 201-389-0877Conference ID: 13747365

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:Matt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com

1 Year MiMedx Chart

1 Year MiMedx Chart

1 Month MiMedx Chart

1 Month MiMedx Chart